NIP
Nicholas Investment Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7,526
| Closed | -$2.07M | – | 222 |
|
|
2024
Q3 | $2.07M | Buy |
+7,526
| New | +$2.07M | 0.19% | 165 |
|
|
2023
Q3 | – | Sell |
-90,351
| Closed | -$17.2M | – | 185 |
|
|
2023
Q2 | $17.2M | Hold |
90,351
| – | – | 1.17% | 29 |
|
|
2023
Q1 | $18.1M | Buy |
90,351
+37,467
| +71% | +$7.51M | 1.38% | 26 |
|
|
2022
Q4 | $12.6M | Buy |
52,884
+4,582
| +9% | +$1.09M | 1.1% | 36 |
|
|
2022
Q3 | $9.67M | Buy |
48,302
+1,222
| +3% | +$245K | 0.9% | 45 |
|
|
2022
Q2 | $6.87M | Sell |
47,080
-39,084
| -45% | -$5.7M | 0.65% | 52 |
|
|
2022
Q1 | $14.1M | Buy |
+86,164
| New | +$14.1M | 1% | 32 |
|
|
2016
Q1 | – | Sell |
-32,953
| Closed | -$3.1M | – | 304 |
|
|
2015
Q4 | $3.1M | Buy |
32,953
+11,568
| +54% | +$1.09M | 0.21% | 200 |
|
|
2015
Q3 | $1.72M | Sell |
21,385
-167
| -0.8% | -$13.4K | 0.12% | 261 |
|
|
2015
Q2 | $2.58M | Sell |
21,552
-26,821
| -55% | -$3.21M | 0.17% | 232 |
|
|
2015
Q1 | $5.05M | Sell |
48,373
-63,088
| -57% | -$6.59M | 0.32% | 117 |
|
|
2014
Q4 | $10.8M | Buy |
111,461
+115
| +0.1% | +$11.2K | 0.68% | 27 |
|
|
2014
Q3 | $8.7M | Buy |
111,346
+68,141
| +158% | +$5.32M | 0.54% | 38 |
|
|
2014
Q2 | $2.73M | Buy |
43,205
+818
| +2% | +$51.7K | 0.16% | 207 |
|
|
2014
Q1 | $2.85M | Buy |
+42,387
| New | +$2.85M | 0.23% | 147 |
|